Procyrion, Inc. logo — Developing catheter-based circulatory support devices to add...

Procyrion, Inc.

Developing catheter-based circulatory support devices to address the needs of heart failure and kidney disease patients

Founded 2005 United States Houston, United States 28 employees Series E Total: $122.40M Health Care, Medical Devices

General Information

Company Name Procyrion, Inc.
Founded Year 2005
Location United States Houston, United States
Founders / Decision Makers
Team member Team member Team member
Employees 28
Industries Health Care, Medical Devices
Funding Stage Series E
Social

BounceWatch is an independent company data service, not affiliated with Procyrion, Inc.. To contact Procyrion, Inc., visit procyrion.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Procyrion, Inc. compare?

A PDF of Procyrion, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Procyrion, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Procyrion, Inc.

Procyrion is a health care startup founded in 2005 and headquartered in the United States. The company is dedicated to improving outcomes for patients with cardiac and renal impairment through its catheter-deployed pump technology, specifically targeting conditions with significant unmet needs. Its flagship product, Aortix™, is a percutaneous mechanical circulatory support device designed to treat cardiorenal syndrome with a rapidly-deployed intra-aortic catheter-based system. As of 05 February 2024, Procyrion secured a $47.70M Series E investment led by Bluebird Ventures and Fannin Innovation Studio. The company's groundbreaking technology and dedicated team position it at the forefront of innovation in treating cardiac and renal impairments. However, it's important to note that Aortix™ is currently in the research and development phase and is not available for sale in any country, adhering to investigational device regulations and limited by federal law to investigational use. This recent investment provides the necessary resources to further develop and potentially bring Aortix™ to market, addressing critical needs in the medical space.

Business keywords: cardiology, circulatory support, catheter-based technology, heart failure, kidney disease, catheter-deployed pump, cardiorenal syndrome, percutaneous devices, innovative medical technology, circulatory assist, Houston, Texas, clinical trials, investigational device

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $10.00M -
05 Feb 2024
Series E $47.70M 2
Bluebird Ventures, Fannin Innovation Studio
05 Feb 2024
Series D $30.00M 3
Bluebird Ventures, Scientific Health Development +1
11 Jul 2019
Series C $16.00M 3
Scientific Health Development, Jefferson River Capital +1
31 Jan 2018
Series B $10.00M 2
Scientific Health Development, Fannin Innovation Studio
09 Oct 2015
Venture Round $5.15M 1
Houston Angel Network
13 Jul 2015
Venture Round $650.00K -
03 Dec 2014
Series A $2.90M -
20 Feb 2013

Procyrion, Inc. Alternatives & Competitors

View All Alternatives
Procyrion, Inc. vs

Self-Expanding Percutaneous Mechanical Circulatory Support

Venture round
75 employees
Health Care, Medical Devices
Procyrion, Inc. vs

Heart Failure is one of the most debilitating medical issues we face. It is the leading cause of hos...

Non Equity Assistance
7 employees
Biotechnology, Health Care
Procyrion, Inc. vs
BioVentrix
BioVentrix United States

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our missi...

Series A
17 employees
Biotechnology, Health Care

FAQ About Procyrion, Inc.

Developing catheter-based circulatory support devices to address the needs of heart failure and kidney disease patients
Procyrion, Inc. was founded in 2005.
Procyrion, Inc. is headquartered in Houston, United States.
Procyrion, Inc. operates in Health Care and Medical Devices. Its work centres on cardiology, circulatory support, catheter-based technology and heart failure.
Procyrion, Inc. has approximately 28 employees.
Procyrion, Inc. has completed 8 funding rounds, raising a total of $122.40M. The latest funding stage is Series E.
Top alternatives and competitors to Procyrion, Inc. include Magenta Medical Ltd., InterShunt Technologies, Inc., BioVentrix, Avenu Medical, EBR Systems, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Procyrion, Inc. and Magenta Medical Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Procyrion, Inc., https://bouncewatch.com/company/procyrion, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes